Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Rangering i aksjer #40953
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Aksjekurs
$0.15137669
Markedsverdi
$58.28K
Endring (1 dag)
11.25%
Endring (1 år)
6.17%
Land
VG
Handel CRISM Therapeutics Corporation (CRTX)

Kategori

Pris CRTX pris med markedsverdi på B
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
CRTX
$0.15137669
Markedsverdi av CRISM Therapeutics Corporation(CRTX)
Markedsverdi: $58.28K
Per August 2026 har CRISM Therapeutics Corporation en markedsverdi på $58.28K. Dette gjør CRISM Therapeutics Corporation til det 40953rd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for CRISM Therapeutics Corporation fra 2003 til 2026
CRTX sammenlignet med topp 5 mest populære stocks
Pris på CRTX Eiendel B Markedsverdi for B Resultater
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$14,149,965 $58.28K
$5.448T +9,347,518,994.09%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$11,489,328 $58.28K
$4.423T +7,589,892,339.23%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$10,806,154 $58.28K
$4.160T +7,138,585,386.14%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$9,515,119 $58.28K
$3.663T +6,285,722,740.82%
CRISM Therapeutics Corporation CRISM Therapeutics Corporation
$7,509,685 $58.28K
$2.891T +4,960,925,706.37%